First Tracks Biotherapeutics (TRAX) Earnings Analysis
First Tracks Biotherapeutics (TRAX) next reports earnings on 2026-08-07, consensus EPS -0.80256 USD. Trailing P/E -13.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TRAX next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | -0.80256 USD |
| Revenue estimate | 0.07B |
TRAX earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
TRAX valuation and analyst view
| Trailing P/E | -13.58 |
|---|---|
| Trailing EPS | -2.81103 USD |
| Price / book | 5.15 |
| Dividend yield | 0.00% |
| Market cap | 1.33B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is First Tracks Biotherapeutics (TRAX)'s next earnings date?
First Tracks Biotherapeutics is next scheduled to report on 2026-08-07, with a consensus EPS estimate of -0.80256 USD and revenue estimate of 0.07B.
What is TRAX's current P/E ratio and EPS?
TRAX trades at a trailing P/E of -13.58 on trailing EPS of -2.811029006694065 USD.
What do analysts rate TRAX?
TRAX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.